Update to my previous post on testing revenue $
Post# of 1418
(Total Views: 230)
Posted On: 08/24/2022 12:09:59 AM
Update to my previous post on testing revenue
Now we know the UTI Panel is $800 reimbursement per the CC call
If they were running 50,000 of them a day
Instead of...
50,000 x $100 = $5M x 365 = $1,825,000,000
That would be...
50,000 x $800 = $40M x 365 = $14.6B
Heck, let's low ball and say they only run 100 of them a day and do nothing else. No other panels. That would be $29.2M with simple math that's not so simple for one. We'll actually two.
Some don't realize how explosive the revenue can be on the Dx side of the business and just thinking Tollovid/r is the cash cow.
Anywho, sounds like the EU announcement coming this week or in the next week.
Quote:
$100 reimbursement per panel probably is very low, but at full capacity, Todos could be raking in the dough.
Now we know the UTI Panel is $800 reimbursement per the CC call
If they were running 50,000 of them a day
Instead of...
50,000 x $100 = $5M x 365 = $1,825,000,000
That would be...
50,000 x $800 = $40M x 365 = $14.6B
Heck, let's low ball and say they only run 100 of them a day and do nothing else. No other panels. That would be $29.2M with simple math that's not so simple for one. We'll actually two.
Some don't realize how explosive the revenue can be on the Dx side of the business and just thinking Tollovid/r is the cash cow.
Anywho, sounds like the EU announcement coming this week or in the next week.
(1)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼